Venetoclax–rituximab holds substantial promise in CLL

06:16 EDT 13 Apr 2018 | Nature Publishing

Original Article: Venetoclax–rituximab holds substantial promise in CLL

More From BioPortfolio on "Venetoclax–rituximab holds substantial promise in CLL"